Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

REGULATION OF PROSTATE CANCER PROGRAMMED CELL DEATH


Collapse Biography 

Collapse Overview 
Collapse abstract
Androgen-withdrawal or blockade causes human prostate cancers to die through an orderly cascade of biochemical events called programmed cell death or apoptosis. Unfortunately, after hormone withdrawal, tumors recur containing cells which are capable of androgen-independent growth. We hypothesize that androgen-insensitivity arises, in part, because tumors develop abnormalities in their ability to undergo apoptosis. This inability to undergo apoptosis allows prostate tumor cells to grow in a hormone-independent fashion. This hypothesis is based on preliminary results from our laboratory which demonstrate that (1) prostate tumor cells overexpressing a protein inhibitor of apoptosis, crmA, grow androgen-independently in nude mice although they are normally hormone dependent, and (2) MAP kinase phosphatase (MKP-1), a protein which is overexpressed in human prostate cancer, blocks apoptosis of cultured prostate cancer cells.

Thus, the goals for this proposal are to (1) determine in animal and tissue culture models whether MKP-1 overexpression blocks androgen- withdrawal and chemotherapy-induced apoptosis, (2) develop a transgenic mouse model in which MKP-1, an inhibitor of apoptosis, drives prostate cancer development, and (3) examine the enzyme targets and location(s) of action of MKP-1.

Information gained from these studies will provide the background and animal models to examine MKP-1 or regulation of apoptosis as a target for antiprostate cancer therapy.
Collapse sponsor award id
R01CA078631

Collapse Time 
Collapse start date
1998-08-14
Collapse end date
2003-04-30

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)